{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:32:25Z","timestamp":1789605145523,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>Diabetic kidney disease (DKD) is a major long-term complication of diabetes mellitus (DM). Given the paucity of data on DKD in Jordan, we aimed to evaluate the prevalence, characteristics and correlates of DKD in Jordanian patients with type 2 DM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This cross-sectional study included 1398 adult patients with type 2 DM who sought medical advice in the endocrinology clinic between March and September 2019. Demographic, clinical and laboratory data were reviewed. DKD was defined as reduced eGFR, and\/or albuminuria. Three regression models were constructed to identify factors associated with CKD stages, albuminuria and DKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 701 (50.14%) patients had DKD, with a median age of 59.71\u2009\u00b1\u200911.36\u2009\u00a0years. Older age, high triglycerides, and low high-density lipoprotein were associated with DKD (multivariable odds ratio [OR]: 1.02, 95% confidence interval [CI]: 1.01\u20131.03, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01; OR: 1.1, 95% CI: 1.01\u20131.2; and OR: 0.98, 95% CI: 0.97\u20130.99, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01 respectively). Metformin and renin-angiotensin system blockers were negatively associated with albuminuria and chronic kidney disease stages (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study demonstrated that approximately one half of patients with type 2 DM had DKD. Further studies are necessary to understand this high prevalence and the underlying factors. Future research are needed to assess implementing targeted community-based intervention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02429-4","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T11:02:43Z","timestamp":1623841363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-9017","authenticated-orcid":false,"given":"Randa I.","family":"Farah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Q.","family":"Al-Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munther S.","family":"Momani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Albtoosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majd","family":"Arabiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad M.","family":"Abdulraheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Aljabiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abufaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"2429_CR1","unstructured":"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes"},{"issue":"2","key":"2429_CR2","first-page":"A78","volume":"6","author":"DW Brown","year":"2009","unstructured":"Brown DW, Mokdad AH, Walke H, As\u2019ad M, Al-Nsour M, Zindah M, Arqoob K, Belbeisi A. Projected burden of chronic, noncommunicable diseases in Jordan. Prev Chronic Dis. 2009;6(2):A78.","journal-title":"Prev Chronic Dis."},{"issue":"5","key":"2429_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","volume":"34","author":"E Ritz","year":"1999","unstructured":"Ritz E, Rychl\u00edk I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999;34(5):795\u2013808. https:\/\/doi.org\/10.1016\/S0272-6386(99)70035-1.","journal-title":"Am J Kidney Dis"},{"key":"2429_CR4","doi-asserted-by":"publisher","first-page":"8637138","DOI":"10.1155\/2017\/8637138","volume":"2017","author":"C Qi","year":"2017","unstructured":"Qi C, Mao X, Zhang Z, Wu H. Classification and differential diagnosis of diabetic nephropathy. J Diabetes Res. 2017;2017:8637138. https:\/\/doi.org\/10.1155\/2017\/8637138.","journal-title":"J Diabetes Res"},{"key":"2429_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00125-004-1599-9","volume":"48","author":"AY Wu","year":"2005","unstructured":"Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, Yoo SJ, Rouillon A, Weir MR. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia. 2005;48:17\u201326. https:\/\/doi.org\/10.1007\/s00125-004-1599-9.","journal-title":"Diabetologia."},{"issue":"1","key":"2429_CR6","first-page":"49","volume":"5","author":"O Gheith","year":"2015","unstructured":"Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacol. 2015;5(1):49\u201356. Published 2015 Oct 9","journal-title":"J Nephropharmacol"},{"issue":"10","key":"2429_CR7","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","volume":"37","author":"KR Tuttle","year":"2014","unstructured":"Tuttle KR, Bakris GL, Bilous RW, Chiang JL, et al. Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care. 2014;37(10):2864\u201383. https:\/\/doi.org\/10.2337\/dc14-1296.","journal-title":"Diabetes Care"},{"key":"2429_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Stevens PE, Bilous RW. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"2429_CR9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825\u201330. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2429_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4314\/wajm.v23i3.28123","volume":"23","author":"MA Al-Homrany","year":"2004","unstructured":"Al-Homrany MA, Abdelmoneim I. Significance of proteinuria in type 2 diabetic patients treated at a primary health care center in Abha City, Saudi Arabia. West Afr J Med. 2004;23(3):211\u20134. https:\/\/doi.org\/10.4314\/wajm.v23i3.28123.","journal-title":"West Afr J Med"},{"issue":"2","key":"2429_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0168-8227(94)90148-1","volume":"26","author":"AA Alzaid","year":"1994","unstructured":"Alzaid AA, Sobki S, De Silva V. Prevalence of microalbuminuria in Saudi Arabians with non-insulin-dependent diabetes mellitus: a clinic-based study. Diabetes Res Clin Pract. 1994;26(2):115\u201320. https:\/\/doi.org\/10.1016\/0168-8227(94)90148-1.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"2429_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L","volume":"15","author":"WH Herman","year":"1998","unstructured":"Herman WH, Aubert RE, Engelgau MM, Thompson TJ, Ali MA, Sous ES, et al. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med. 1998;15(12):1045\u201351. https:\/\/doi.org\/10.1002\/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L.","journal-title":"Diabet Med."},{"issue":"6","key":"2429_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.5144\/0256-4947.2008.420","volume":"28","author":"N Taleb","year":"2008","unstructured":"Taleb N, Salti H, Al-Mokaddam M, Merheb M, Salti I, Nasrallah M. Prevalence and determinants of albuminuria in a cohort of diabetic patients in Lebanon. Ann Saudi Med. 2008;28(6):420\u20135. https:\/\/doi.org\/10.5144\/0256-4947.2008.420.","journal-title":"Ann Saudi Med"},{"key":"2429_CR14","first-page":"583","volume":"41","author":"A Sarraf","year":"2005","unstructured":"Sarraf A, Al Dhubaib AS, Al Banai DJ, El Shazly SK, Medhat K. Prevalence of diabetic nephropathy and associated factors in type 2 diabetes mellitus in primary health care in Kuwait. Bull Alex Fac Med. 2005;41:583\u201391.","journal-title":"Bull Alex Fac Med"},{"issue":"10","key":"2429_CR15","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/sj.ki.5001882","volume":"70","author":"ME Pavkov","year":"2006","unstructured":"Pavkov ME, Knowler WC, Bennett PH, Looker HC, Krakoff J, Nelson RG. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int. 2006;70(10):1840\u20136. https:\/\/doi.org\/10.1038\/sj.ki.5001882.","journal-title":"Kidney Int"},{"issue":"12","key":"2429_CR16","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/sj.ki.5000270","volume":"69","author":"BR Hemmelgarn","year":"2006","unstructured":"Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006;69(12):2155\u201361. https:\/\/doi.org\/10.1038\/sj.ki.5000270.","journal-title":"Kidney Int."},{"issue":"5","key":"2429_CR17","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2215\/CJN.09291010","volume":"6","author":"JM Lachin","year":"2011","unstructured":"Lachin JM, Viberti G, Zinman B, Haffner SM, Aftring RP, Paul G, et al. Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy. Clin J Am Soc Nephrol. 2011;6(5):1032\u201340. https:\/\/doi.org\/10.2215\/CJN.09291010.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"9","key":"2429_CR18","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1681\/ASN.2018010050","volume":"29","author":"M Lee","year":"2018","unstructured":"Lee M, Katerelos M, Gleich K, Galic S, Kemp BE, Mount PF, et al. Phosphorylation of acetyl-CoA carboxylase by AMPK reduces renal fibrosis and is essential for the anti-fibrotic effect of metformin. J Am Soc Nephrol. 2018;29(9):2326\u201336. https:\/\/doi.org\/10.1681\/ASN.2018010050.","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"2429_CR19","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.3390\/ijms21124239","volume":"21","author":"D Kawanami","year":"2020","unstructured":"Kawanami D, Takashi Y, Tanabe M. Significance of metformin use in diabetic kidney disease. Int J Mol Sci. 2020;21(12):4239. Published 2020 Jun 14. https:\/\/doi.org\/10.3390\/ijms21124239.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2429_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861\u20139. https:\/\/doi.org\/10.1056\/NEJMoa011161.","journal-title":"N Engl J Med."},{"issue":"12","key":"2429_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851\u201360. https:\/\/doi.org\/10.1056\/NEJMoa011303.","journal-title":"N Engl J Med."},{"issue":"2","key":"2429_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.semnephrol.2003.11.003","volume":"24","author":"HH Parving","year":"2004","unstructured":"Parving HH, Andersen S, Jacobsen P, Christensen PK, Rossing K, Hovind P, et al. Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points. Semin Nephrol. 2004;24(2):147\u201357. https:\/\/doi.org\/10.1016\/j.semnephrol.2003.11.003.","journal-title":"Semin Nephrol."},{"issue":"2","key":"2429_CR23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000477946","volume":"42","author":"FY Hsu","year":"2017","unstructured":"Hsu FY, Lin FJ, Ou HT, Huang SH, Wang CC. Renoprotective effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic patients with proteinuria. Kidney Blood Press Res. 2017;42(2):358\u201368. https:\/\/doi.org\/10.1159\/000477946.","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"2429_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12882-018-1001-7","volume":"19","author":"PLGC Liyanage","year":"2018","unstructured":"Liyanage PLGC, Lekamwasam S, Weerarathna TP, Srikantha DWSY. Prevalence of normoalbuminuric renal insufficiency and associated clinical factors in adult onset diabetes. BMC Nephrol. 2018;19(1):200. Published 2018 Aug 13. https:\/\/doi.org\/10.1186\/s12882-018-1001-7.","journal-title":"BMC Nephrol"},{"issue":"9","key":"2429_CR25","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1097\/HJH.0b013e3283495cd6","volume":"29","author":"G Penno","year":"2011","unstructured":"Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens. 2011;29(9):1802\u20139. https:\/\/doi.org\/10.1097\/HJH.0b013e3283495cd6.","journal-title":"J Hypertens."},{"issue":"24","key":"2429_CR26","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1001\/jama.289.24.3273","volume":"289","author":"HJ Kramer","year":"2003","unstructured":"Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289(24):3273\u20137. https:\/\/doi.org\/10.1001\/jama.289.24.3273.","journal-title":"JAMA"},{"issue":"1","key":"2429_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.ackd.2010.10.003","volume":"18","author":"PN Van Buren","year":"2011","unstructured":"Van Buren PN, Toto R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis. 2011;18(1):28\u201341. https:\/\/doi.org\/10.1053\/j.ackd.2010.10.003.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"2429_CR28","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.2337\/dc16-1246","volume":"39","author":"GT Russo","year":"2016","unstructured":"Russo GT, De Cosmo S, Viazzi F, Pacilli A, Ceriello A, Genovese S, et al. Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative. Diabetes Care. 2016;39(12):2278\u201387. https:\/\/doi.org\/10.2337\/dc16-1246.","journal-title":"Diabetes Care."},{"issue":"11","key":"2429_CR29","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.2337\/dc12-0306","volume":"35","author":"J Morton","year":"2012","unstructured":"Morton J, Zoungas S, Li Q, Patel AA, Chalmers J, Woodward M, et al. Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study. Diabetes Care. 2012;35(11):2201\u20136. https:\/\/doi.org\/10.2337\/dc12-0306.","journal-title":"Diabetes Care."},{"issue":"2","key":"2429_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00125-010-1951-1","volume":"54","author":"TM Davis","year":"2011","unstructured":"Davis TM, Ting R, Best JD, Donoghoe MW, Drury PL, Sullivan DR, et al. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia. 2011;54(2):280\u201390. https:\/\/doi.org\/10.1007\/s00125-010-1951-1.","journal-title":"Diabetologia."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02429-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02429-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02429-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T11:04:26Z","timestamp":1623841466000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02429-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2429"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02429-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"14 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by University of Jordan Hospital Institutional Review Board and all procedures performed were in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the World Medical Association Declaration of Helsinki. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"NA\/Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"223"}}